Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Colistin resistant bacteria found in mothers and newborn babies in Nigeria

General Research

Researchers from the Ineos Oxford Institute for antimicrobial research (IOI) and Cardiff University have found evidence that bacteria resistant to colistin, a last-resort antibiotic, were present in mothers and babies under a week old in Nigeria in 2016, despite limited clinical use of colistin at that time in the country. The findings have been published in Nature Communications.

Risk factors for faster aging in the brain revealed in new study

General Research

Researchers from the Nuffield Department of Clinical Neurosciences at the University of Oxford have used data from UK Biobank participants to reveal that diabetes, traffic-related air pollution and alcohol intake are the most harmful out of 15 modifiable risk factors for dementia

New funding for development of world's first lung cancer vaccine

General Research

Researchers at the University of Oxford, the Francis Crick Institute and University College London have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine.

Funding to compare imaging modalities for liver cancer detection

General Research

The DeLIVER early detection of hepatocellular carcinoma research team will evaluate non-contrast-enhanced MRI and compare it to standard of care ultrasound in a cohort of patients under surveillance for liver cancer.

New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites

General Research

Scientists at the University of Oxford and the University of Edinburgh have launched a pioneering study that examines how the immune system responds to repeated malaria infections. The BIO-004 study is being run in partnership between the Department of Biochemistry (Draper Lab, based in the Kavli Institute for Nanoscience Discovery), the University of Edinburgh (Spence Lab, Institute of Immunology and Infection Research) and the Oxford Vaccine Group (part of the Department of Paediatrics). BIO-004 will provide a unique insight into how the immune system adapts over the first few malaria infections of life, learning to tolerate malaria parasites and developing natural immunity to severe illness.

Artificial Intelligence (AI) generated food images look tastier than real ones

General Research

Researchers have announced an intriguing discovery – consumers generally prefer Artificial Intelligence (AI)-generated images of food over real food images, especially when they are unaware of their true nature. The new findings have been published in Food Quality and Preference.

Oxford wins funding to set up UK’s first registry of those at risk of type 1 diabetes

General Research

Oxford researchers have received funding to set up a UK registry for children and adults who are at risk of type 1 diabetes (T1D), by testing positive for diabetes autoantibodies.

Ground-breaking Research Unveils Cost-Effective Model to Boost COVID-19 Immunisation in Developing Countries

General Research

In a ground-breaking development, a cost-effective strategy to enhance COVID-19 vaccination rates among rural populations in developing countries has been unveiled in a recent study published in Nature. Titled "Last-mile delivery increases vaccine uptake in Sierra Leone," the research, conducted by a collaborative team from the International Growth Centre, University of Oxford, Yale University School of Management, and Wageningen University, introduces a simple yet widely applicable intervention to enhance vaccine accessibility.

Antimalarial treatments more likely to fail in children with acute malnutrition

General Research

Children with acute malnutrition across Africa and Asia have a higher risk of treatment failure and malaria reinfection, even after being given the best currently available and recommended malaria treatment. Researchers from the Infectious Diseases Data Observatory (IDDO) at Oxford University analysed data from over 11,000 young children for this study, published in Lancet Global Health.

Research shows comforting babies eases parental stress in painful procedures

Research

The Neuroimaging Group, at the Department of Paediatrics, in collaboration with Bliss, the charity for babies born premature or sick, has launched a new suite of information resources for parents of neonates, designed to make them feel more confident about being involved in the care of their babies.

Report makes recommendations to remove interdisciplinary research barriers

General Research

The X-Net project – a partnership between the Universities of Edinburgh, Dundee, and Oxford – publishes its recommendations following extensive consultation with the biomedical research community.

AI reveals prostate cancer is not just one disease

General Research

Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer, which could revolutionise how the disease is diagnosed and treated in the future.

Kusuma Trust supports research aiming to unpick complex link between diabetes and heart disease

General Research

An innovative research project with the potential for transforming our understanding and treatment of the long-term cardiovascular consequences of diabetes will soon get underway at Oxford University thanks to support from the Kusuma Trust.

New study links hospital privatisation to worse patient care

General Research

A new review has concluded that hospitals that are privatised typically deliver worse quality care after converting from public ownership. The study, led by University of Oxford researchers, has been published in The Lancet Public Health.

Paediatric Neuroimaging Group launches animation series to support parents of premature infants

General Public Engagement with Research Research

Professor Caroline Hartley, Principal Investigator, and Dr Marianne van der Vaart, Postdoctoral Researcher, in the Paediatric Neuroimaging Group at the Department of Paediatrics, have today launched a series of animations aimed at improving parental understanding of brain development in premature infants, and the effect it has on breathing and apnoeas (the cessation of breathing).

The lasting legacy of Norman Heatley, the unassuming penicillin pioneer who changed the course of medicine

Events Research

Norman Heatley is often described as the unsung hero of the penicillin story. A recent PhD graduate with a genius for invention, he became a pivotal member of the Oxford team that developed the miracle drug in the early 1940s. A new Medium article features an interview with Norman's eldest daughter, Rose Heatley, about his work, legacy and her memories of him as a father.

Removing bias from healthcare AI tools

General Research

Rapid advances in Artificial Intelligence (AI) have opened the way for the creation of a huge range of new healthcare tools, but to ensure that these tools do not exacerbate pre-existing health inequities, researchers urge the use of more representative data in their development.

Study reveals high number of persistent COVID-19

Coronavirus COVID-19 General Research

A new study led by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published today in the journal Nature.

Study shows UK offshores emissions through used vehicle exports

General Research

A new study by researchers at Nuffield Department of Population Health’s Demographic Science Unit reveals that used vehicles sent from Great Britain to lower-income countries fail British roadworthiness standards, are more polluting and less fuel efficient than those sent to be scrapped.

Regius Professor of Medicine, Sir John Bell, to step down from Oxford role

Awards and Appointments General Research

The University of Oxford has announced today that Professor Sir John Bell will step down from his role as Regius Professor of Medicine on 31 March, to take up the new position of President of Ellison Institute of Technology (EIT) Oxford. He will also become Co-CEO of EIT Global, alongside Dr David Agus.

Load More